This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Necrotizing enterocolitis is a life-threatening condition in preterm neonates that is associated with severe morbidity and mortality. Several studies have suggested that probiotics can potentially decrease the risk of developing necrotizing enterocolitis via several proposed mechanisms of action, including increasing diversity of the intestinal flora. However, due to a lack of standardized study designs, including variability in product selection, dose, time of initiation, and duration, as well as a concern for safety in this vulnerable population, the use of probiotics in this population remains controversial. Regulations for testing of products and well-validated dosing regimens are needed before considering routine use of probiotics in these high-risk patients.
- Copyright © 2016 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
- Article
- Abstract
- Educational Gap
- Objectives
- Background
- Development and Pathophysiology of Necrotizing Enterocolitis
- Gastrointestinal Flora of the Neonate
- Literature Review of Probiotics
- Application in Current Practice
- Clinical Controversies
- Treatment Initiation and Duration
- Safety Concerns
- Conclusions
- Acknowledgement
- Footnotes
- References
- Figures & Data
- Info & Metrics
- Comments
- Quiz
Related Articles
Cited By...
- No citing articles found.